Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.
